“COVID-19 hasn’t disappeared, however, and for the more than 400 million people living with diabetes worldwide, very real risks and impacts from the pandemic remain,” Jamie Hartmann-Boyce writes.
Jamie Hartmann-Boyce
Jamie Hartmann-Boyce is an assistant professor of Health Promotion and Policy at UMass Amherst. Her research focuses on combining and evaluating research to inform health policy, including in the areas of tobacco control, electronic cigarettes, diet, physical activity, and management of long-term conditions. Hartmann-Boyce is also co-lead of the NIH-FDA Center for the Assessment of Tobacco Products Policy Analysis and Dissemination Core. She has a particular interest in diabetes, having lived with type 1 diabetes since childhood, works closely with Cochrane, and leads a number of research programs focusing on smoking cessation and electronic cigarettes. Hartmann-Boyce works hard to engage the public in my research and have been involved in podcasts, blogging, tv and radio interviews, and songwriting to communicate research results outside of academia.
